Erythrocyte CD38 as a prognostic marker in cancer

References

• Pekala PH, Anderson BM. Non-oxidation—reduction reac-tions of pyridine nucleotide. In: Everse J, Anderson B, You K-S, editors. The pyridine nucleotide coenzymes. New York: Academic Press; 1982. p 325–377.
   Google Scholar
• Kim H, Jacobson EL, Jacobson MK. NAD glycohydrolases: A possible function in calcium homeostasis. Mol Cell Biochem 1994;138:237–243.
   Google Scholar
• De Wolf MJS, Van Dessel GAF, Lagrou AR, Hilderson Hll, Dierick WSH. Topography, purification and characterization of thyroidal NAD glycohydrolase. Biochem J 1985;226: 415–427.
   PubMed Web of Science ®Google Scholar
• Zocchi E, Franco L, Guidea L, Benatti U, Bargellesi A, Malavasi F, et al. A single protein immunologically identified as CD38 displays NAD glycohydrolase, ADP-ribosyl cyclase and cyclic ADP-ribose hydrolase activities at the outer surface of human erythrocytes. Biochem Biophys Res Commun 1993; 196:1459–1465.
   PubMed Web of Science ®Google Scholar
• Malavasi F, Funaro A, Roggero S, Horenstein A, Calosso L, Mehta K. Human CD38: A glycoprotein in search of a function. Immunol Today 1994;15:95–97.
   PubMedGoogle Scholar
• Howard M, Grimaldi JC, Bazan JF, Lund FE, Santos-Argumedo L, Parkhouse RME, et al. Formation and hydrolysis of cyclic ADP-ribose catalyzed by lymphocyte antigen CD38. Science 1993;262: 1056–1059.
   PubMed Web of Science ®Google Scholar
• Takasawa S, Togho A, Noguchi N, Koguma T, Nata K, Sugimoto T, et al. Synthesis and hydrolysis of cyclic ADP-ribose by human leukocyte antigen CD38 and inhibition of the hydrolysis by ATP. J Biol Chem 1993;268:26052–26054.
   PubMed Web of Science ®Google Scholar
• Kim H, Jacobson EL, Jacobson MK. Synthesis and degradation of cyclic ADP-ribose by NAD glycohydrolases. Science 1993;261:1330–1333.
   Google Scholar
• Muller-Steffner HM, Augustine A, Schuber F. Mechanism of cyclization of pyridine nucleotides by bovine spleen NAD± glycohydrolase. J Biol Chem 1996;271:23967–23972.
   Google Scholar
• Moss J, Vaughan M. ADP-ribosylation of guanyl nucleotide binding regulatory proteins by bacterial toxins. Adv Enzymol 1998;61:303–379.
   Google Scholar
• Mehta K, Shahid U, Malavasi F. Human CD38, a cell-surface protein with multiple functions. FASEB J 1996;10: 1408–1417.
   PubMed Web of Science ®Google Scholar
• Lund F, Solvason N, Grimaldi JC, Parkhouse RIVIE, Howard M. Murine CD38: An immunoregulatory ectoenzyme. Immunol Today 1995;16: 469–473.
   PubMedGoogle Scholar
• Kim UH, Han MK, Park BH, Kim HR, An NH. Function of NAD glycohydrolase in ADP-ribose uptake from NAD by human erythrocytes. Biochim Biophys Acta 1993;1178: 121–128.
   Google Scholar
• Albeniz I, Demir 6, Nurten R, Bermek E. NAD glycohy-drolase activities and ADP-ribose uptake in erythrocytes from normal subjects and cancer patients. Biosci Rep 2004;24: 41–53.
   Google Scholar
• Harlow E, Lane D. A laboratory manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 1988.
   Google Scholar
• Prall YG, GambhirAmpy FR. Acetyl cholinesterase: Anenzymatic marker of human red blood cell aging. Life Sci 1998;63:177–184.
   PubMedGoogle Scholar
• Graeff RM, Walseth TF, Fryxell K, Branton WD, Lee HC. Enzymatic synthesis and characterization of cyclic GDP-ribose. A procedure for distinguishing enzymes with ADP-ribosyl cyclase activity. J Biol Chem 1994;269:30260–30267.
   Google Scholar
• Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227: 680–685.
   PubMed Web of Science ®Google Scholar
• Gershoni JM, Palade GE. Protein blotting: Principles and applications. Anal Biochem 1983;131:1–15.
   PubMed Web of Science ®Google Scholar
• Deaglio S, Mehta K, Malavasi F. Human CD38: A (r)evolutionary story of enzymes and receptors. Leuk Res 2001;25: 1–12.
   PubMed Web of Science ®Google Scholar
• Kontani K, Nishina H, Ohoka Y, Takahashi K, Katada T. NAD glycohydrolase specifically induced by retinoic acid in human leukemic HL-60 cells. Identification of the NAD glycohydrolase as leukocyte cell surface antigen CD38. J Biol Chem 1993;268: 16895–16898.
   PubMed Web of Science ®Google Scholar
• Yalcintepe L, Ercelen S, Adni-Cmar S, Badur S, Tiryaki D, Bermek E. Hemin-dependent induction and internalization of CD38 in K562 cells. J Cell Biochem 2003;90: 379–386.
   PubMed Web of Science ®Google Scholar
• Daugas E, Cande C, Kroemer G. Erythrocytes: Death of a mummy. Cell Death Differ 2001;8:1131–1133.
   PubMed Web of Science ®Google Scholar
• Umar S, Malavasi F, Mehta K. Post-translational modification of CD38 protein into a high molecular weight form alters its catalytic properties. J Biol Chem 1996;271: 15922–15929.
   PubMed Web of Science ®Google Scholar
• Matutes E. New additions to antibody panels in the characterisation of chronic lymphoproliferative disorders. J Chin Path 2002;55:180–183.
   PubMed Web of Science ®Google Scholar
• Watson JM, Sensintaffar JL, Berek JS, Martinez-Maza O. Constitutive production of interleukin 6 by ovarian cancer cell lines and by primary ovarian tumor cultures. Cancer Res 1990; 50:6959–6965.
   Google Scholar
• Siegall CB, Schwab G, Nordan RP, FitzGerald DJ, Pastan I. Expression of the interleukin 6 receptor and interleukin 6 in prostate carcinoma cells. Cancer Res 1990;50: 7786–7788.
   PubMed Web of Science ®Google Scholar
• Shim KS, Kim KH, Han WS, Park EB. Elevated serum levels of transforming growth factor-betal in patients with colorectal carcinoma: Its association with tumor progression and its significant decrease after curative surgical resection. Cancer 1999;85:554–561.
   PubMed Web of Science ®Google Scholar
• Elaraj DM, Weinreich DM, Varghese S, Puhlmann M, Hewitt SM, Caroll NM, et al. The role of interleukin 1 in growth and metastasis of human cancer xenografts. Chin Cancer Res 2006;12:1088–1096.
   Web of Science ®Google Scholar
• Bendre MS, Margulies AG, Walser B, Akel NS, Bhattacharrya SR, Skinner A, et al. Tumor-derived interleukin-8 stimulates osteolysis independent of the receptor activator of nuclear factor-kappaB ligand pathway. Cancer Res 2005;65: 11001–11009.
   PubMed Web of Science ®Google Scholar
• Lahm H, Wyniger J, Hertig S, Yilmaz A, Fischer JR, Givel JC, et al. Secretion of bioactive granulocyte-macrophage colony-stimulating factor by human colorectal carcinoma cells. Cancer Res 1994;54:3700–3702.
   PubMed Web of Science ®Google Scholar
• Blay JY, Negrier S, Comaret V, Attali S, Goillot E, Merrouche Y, et al. Serum level of interleukin 6 as a prognosis factor in metastatic renal cell carcinoma. Cancer Res 1992;52: 3317–3322.
   PubMed Web of Science ®Google Scholar
• Michalaki V, Syrigos K, Charles P, Waxman J. Serum levels of IL-6 and TNF-alpha correlate with clinicopathological features and patient survival in patients with prostate cancer. Br J Cancer 2004;90:2312–2316.
   PubMed Web of Science ®Google Scholar
• Wise GJ, Marella VK, Talluri G, Shirazian D. Cytokine variations in patients with hormone treated prostate cancer. J Urol 2000;164:722–725.
   PubMed Web of Science ®Google Scholar
• Zhang GJ, Adachi I. Serum interleukin-6 levels correlate to tumor progression and prognosis in metastatic breast carcinoma. Anticancer Res 1999;19:1427–1432.
   PubMed Web of Science ®Google Scholar
• Galizia G, Lieto E, De Vita F, Romano C, Orditura M, Castellano P, et al. Circulating levels of interleukin-10 and interleukin-6 in gastric and colon cancer patients before and after surgery: Relationship with radicality and outcome. J Interferon Cytokine Res 2002;22:473–482.
   PubMed Web of Science ®Google Scholar
• Scambia G, Testa U, Benedetti P, Foti E, Martucci R, Gadducci A, et al. Prognostic significance of interleukin 6 serum levels in patients with ovarian cancer. Br J Cancer 1995; 71:354–356.
   PubMed Web of Science ®Google Scholar
• Di Nisio M, Niers TM, Reitsma PH, Buller HR. Plasma cytokine and P-selectin levels in advanced malignancy: Prognostic value and impact of low-molecular weight heparin administration. Cancer 2005;104:2275–2281.
   PubMed Web of Science ®Google Scholar
• Macri A, Versaci A, Loddo S, Scuderi G, Travagliante M, Trimarchi G, et al. Serum levels of interleukin lbeta, interleukin 8 and tumour necrosis factor alpha as markers of gastric cancer. Biomarkers 2006;11:184–193.
   PubMed Web of Science ®Google Scholar
• Mroczko B, Szmitkowski M, Okulczyk B. Hematopoietic growth factors in colorectal cancer patients. Chin Chem Lab Med 2003;41:646–651.
   PubMedGoogle Scholar
• Coussens LM, Werb Z. Inflammation and cancer. Nature 2002;420:860–867.
   PubMed Web of Science ®Google Scholar
• Hedin KE. Chemokines: New, key players in the pathobiology of pancreatic cancer. Int J Gastrointest Cancer 2002;31: 23–29.
   PubMedGoogle Scholar
• Rollins BJ. Inflammatory Chemokines in cancer growth and progression. Eur J Cancer 2006;42:760–767.
   PubMed Web of Science ®Google Scholar
• Ruegg C. Leukocytes, inflammation, and angiogenesis in cancer: Fatal attractions. J Leukoc Biol 2006;80:682–684.
   PubMed Web of Science ®Google Scholar
• Lande R, Urbani F, Di Carlo B, Sconocchia G, Deaglio S, Funaro A, et al. CD38 ligation plays a direct role in the induction of IL-1 beta, IL-6, and IL-10 secretion in resting human monocytes. Cell Immunol 2002;220:30–38.
   PubMed Web of Science ®Google Scholar
• Ceyhan BB, Demiralp E, Çelikel T. Analysis of pleural effusion using flow cytometry. Respiration 1996;63:17–24.
   Google Scholar
• Ceyhan BB, Özg-ün S, Çelikel T, Yalçin M, Koç M. IL-8 in pleural effusion. Resp Med 1996;90:215–221.
   PubMed Web of Science ®Google Scholar